|
|
| (40 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| − | {{Team:Tokyo Tech/template2015}}
| |
| − | <html>
| |
| − | <head>
| |
| − | <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
| |
| − | <meta name="generator" content="MediaWiki 1.16.5" />
| |
| − | <style type="text/css">
| |
| − | table{
| |
| − | margin-left: auto;
| |
| − | margin-right: auto;
| |
| − | margin-top:0px;
| |
| − | }
| |
| − | </style>
| |
| − | </head>
| |
| − | <body>
| |
| − | <div id="titlearea">
| |
| − | <h1>Realizing the Payoff Matrix</h1>
| |
| − | </div>
| |
| − | <div id="titlebottom">
| |
| − | </div>
| |
| − | <div class="texttop">
| |
| − | <img src="https://static.igem.org/mediawiki/2015/a/a4/Tokyo_Tech_textarea_top.png">
| |
| − | </div>
| |
| − | <div class="textarea">
| |
| − | <h2 class="content2">contents</h2>
| |
| − | <h3 class="link"><a href="#Introduction">1. Introduction</a></h3>
| |
| − | <h3 class="link"><a href="#Summary">2. Summary of the Experiment</a></h3>
| |
| − | <h3 class="link2"><a href="#Summary1">2.1. Realizing the Payoff Matrix of Prisoner A <i>coli</i></a></h3>
| |
| − | <h3 class="link2"><a href="#Summary2">2.2. Realizing the Payoff Matrix of Prisoner B <i>coli</i></a></h3>
| |
| − | <h3 class="link"><a href="#Results">3. Results</a></h3>
| |
| − | <h3 class="link2"><a href="#Result1">3.1. Realizing the Payoff Matrix of Prisoner A <i>coli</i></a></h3>
| |
| − | <h3 class="link2"><a href="#Result2">3.2. Realizing the Payoff Matrix of Prisoner B <i>coli</i></a></h3>
| |
| − | <h3 class="link"><a href="#Materials">4. Materials and Methods</a></h3>
| |
| − | <h3 class="link2"><a href="#Const">4.1. Construction</a></h3>
| |
| − | <h3 class="link2"><a href="#Protocol">4.2. Assay Protocol</a></h3>
| |
| − | <h3 class="link3"><a href="#Protol1">4.2.1. C4HSL-dependent CmR expression assay ([Cm] = 75 microg/mL)</a></h3>
| |
| − | <h3 class="link3"><a href="#Protol2">4.2.2. 3OC12HSL concentration-dependent CmR expression assay</a></h3>
| |
| − | <h3 class="link3"><a href="#Protol3">4.2.3. Chloramphenicol-dependent Growth Assay with ssrA tag</a></h3>
| |
| − | <h3 class="link3"><a href="#Protol4">4.2.4. C4HSL-dependent CmR expression assay ([Cm] = 75 microg/mL)</a></h3>
| |
| − | <h3 class="link"><a href="#Reference">5. Reference</a></h3>
| |
| − | <br>
| |
| − | </div>
| |
| − | <div class="textbottom">
| |
| − | <img src="https://static.igem.org/mediawiki/2015/9/97/Tokyo_Tech_textarea_bottom.png">
| |
| − | </div>
| |
| − | <div class="texttop">
| |
| − | <img src="https://static.igem.org/mediawiki/2015/a/a4/Tokyo_Tech_textarea_top.png">
| |
| − | </div>
| |
| − | <div class="textarea">
| |
| − | <h2 id="Introduction" class="smalltitle">1. Introduction</h2>
| |
| − | <p class="text">We genetically engineered two prisoner <i>coli</i>, Prisoner A and Prisoner B. They are able to cooperate or to defect. The genetic circuits, with the improved chloramphenicol resistant protein(CmR) part, of Prisoner A and B are shown in Fig. 3-2-1-1. Our goal in this project is to realize the payoff matrix (Fig. 3-2-1-2) with the four types of growth inhibition. Using the improved plasmids we constructed, our <i>E.coli</i> version payoff matrix is realized through wet experiments. </p>
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/9/93/Tokyo_Tech_realizing_summary1.png" width="600px"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-2-1-1.</strong> C4HSL-dependent CmR expression</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| | | | |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | <h2 id="Summary" class="smalltitle">2. Summary of the Experiment</h2>
| |
| − | <h3 id="Summary1" class="sub5">2.1. Realizing the Payoff Matrix of Prisoner A <i>coli</i></h3>
| |
| − | <p class="text2">The cell growth of the Prisoner <i>colis</i> containing the pairs of plasmids (1) and (2) in the lower chloramphenicol (Cm) concentration (75 microg/mL) were measured and the payoff matrix was realized.</p>
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/3b/Tokyo_Tech_realizing3.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-2-1-1.</strong> C4HSL-dependent CmR expression</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table><br>
| |
| − | <h3 id="Summary1" class="sub5">2.2. Realizing the Payoff Matrix of Prisoner B <i>coli</i></h3>
| |
| − | <p class="text2">We have prepared a new pair of plasmids, (3) and (4), as in the following (Fig. 3-2-2-5.). The cell growth of the Prisoner colis containing the pairs of plasmids (3) and (4) in the lower chloramphenicol (Cm) concentration (75 microg/mL) and also in the lower 3OC12HSL concentration were measured and the payoff matrix was realized.</p>
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/a/a2/Tokyo_Tech_realizing4.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-2-1-1.</strong> C4HSL-dependent CmR expression</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table><br>
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/36/Tokyo_Tech_c4HSL_summary2.png" width="600px"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-2-1.</strong> C4HSL-dependent CmR expression</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <p class="text2">We confirmed the function of C4HSL-dependent CmR expression by measuring the optical density of the cultures containing chloramphenicol (Cm) (Fig. 3-1-2-1.). In this experiment we prepared four cells which contain different sets of plasmids, (1), (2), (3), and (4) (Fig. 3-1-2-2.). C4HSL and chloramphenicol was added into the medium containing the cells. The optical density was measured every hour for eight hours to estimate the concentration of the cell. (1), and (2) are the cooperating and defecting prisoner <i>coli</i> A, respectively. (3), and (4) are the negative control for (1), and (2), respectively.</p>
| |
| − |
| |
| − |
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/2/21/Tokyo_Tech_c4HSLsummary4.png" width="450px"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-2-2.</strong> Plasmids for the experiment of C4HSL-dependent CmR expression</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <h3 id="Summary2" class="sub5">2.2. Insertion of an ssrA degradation tag to CmR</h3>
| |
| − | <p class="text2">At the first stage of wet experiment, Prisoner cell A and B, which are the initially designed circuits showed leaky expression of CmR. Cells showed active growth even in the absence of AHL when the cell harboring the pairs of plasmids (1) and (2) in Prisoner <i>coli</i> A (Fig. 3-1-2-2.). As a result of our modeling, the influence of the leakage was not reduced by increasing the Cm concentration, which was one of our solutions. (link to modelingリンクさせる！！)<br>
| |
| − | For precise implementation of our payoff matrix, suggestions from modeling (link to modelingリンクさせる!!) allowed us to successfully solve the influence of the leakage by adding an ssrA tag right after the CmR gene (Pcon_<i>rhlR</i>_TT_Plux_CmRssrA, <a href="http://parts.igem.org/Part:BBa_K1632023">BBa_K1632023</a>) (Fig. 3-1-2-3.). Protein with an ssrA tag is easily degraded by ClpXP and ClpAP that <i>E.coli</i> originally have. The optical density was measured every hour for eight hours to estimate the growth of the Prisoner <i>coli</i> with the improved parts (Pcon_<i>rhlR</i>_TT_Plux_CmRssrA).
| |
| − | </p><br>
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/c/c8/Tokyo_Tech_c4HSL_summary5.png" width="400px"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-2-3.</strong> The improved parts, <a href="http://parts.igem.org/Part:BBa_K1632023">BBa_K1632023</a>, we constructed</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table><br>
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/36/Tokyo_Tech_c4HSL_summary6.png" width="400px"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="940px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-2-4.</strong> Cells for the experiment to measure C4HSL-dependent CmR expression</h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table><br>
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | <h3 id="Summary3" class="sub5">2.3. Realizing the payoff matrix</h3>
| |
| − | <h3 id="Summary31" class="sub6">2.3.1. Determining the ideal Cm Concentration</h3>
| |
| − | <p class="text3">Using the improved plasmid we constructed, our <i>E.coli</i> version payoff matrix was replicated through wet experiments. The order of the ODs were as expected. (もしくは We tried to realize the payoff matrix.) However, from the results, the difference between “middle” and “high” growth inhibition was hardly observable. <br>
| |
| − | The growth rate of the Prisoner cells (5) and (6), grown in different Cm concentration (50, 75, 100microg/mL) without C4HSL, were observed. (refer protocol 4-2-3)
| |
| − | </p>
| |
| − | <h3 id="Summary32" class="sub6">2.3.2. Payoff matrix with the lower Cm Concentration</h3>
| |
| − | <p class="text3">Using the lower Cm concentration (75microg/mL), the growth of the Prisoner cells (5) and (6) were measured to realize the payoff matrix.</p>
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | <h2 id="Results" class="smalltitle">3. Results</h2>
| |
| − | <h3 id="Result1" class="sub5">3.1. Arabinose dependent FimE expression</h3>
| |
| − | <p class="text2">私たちは、4種類のarabinose濃度でFimBが働くかどうかを、GFPを用いたレポーターアッセイによって確かめた。
| |
| − | Figure(図番号) は、default ONのサンプルが、arabinose誘導によって、OFF状態に切り替わった結果を示している。
| |
| − | またFigure(図番号)は、default OFFのサンプルが、arabinose誘導によって、ON状態に切り替わった結果を示している。
| |
| − | Figure(図番号) shows our experimental results of FimB and Fimswitch. From the results of the reporter cell C and D, inversion from ON to OFF and OFF to ON by endogenous proteins are negligible. レポーターセルE,Fの結果から、FImEの発現はヒストグラムの波形にほとんど影響を与えないことがわかる。
| |
| − | 以上の2つの結果から、FimBが理想的に両反転を起こしていることがわかる。
| |
| − | </p>
| |
| − | <table width="940 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="940px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/1/1a/Tokyo_Tech_arabinose_fimB_result1.png" width="800px"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-4-3-1.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <h3 id="Result2" class="sub5">3.2. FLA analysis</h3>
| |
| − | <p class="text2">写真とシークエンスデータ</p>
| |
| − | <h2 id="Materials" class="smalltitle">4. Materials and Methods</h2>
| |
| − | <h3 id="Const" class="sub5">4.1. Construction</h3>
| |
| − | <h3 class="sub5">-Strain</h3>
| |
| − | <p class="text2">All the samples were JM2.300 strain.</p>
| |
| − | <h3 class="sub5">-Plasmids</h3>
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | <p class="text2">(1) Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1) + Plac_lasI (pSB3K3)</p>
| |
| − | <table width="980 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="980px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/be/Tokyo_Tech_Pcon_rhlR_TT_Plux_CmRssrA_Plac_lasI.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-4-1.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <p class="text2">(2) Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1) +promoter less_lasI (pSB3K3)</p>
| |
| − | <table width="980 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="980px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/2/24/Tokyo_Tech_Pcon_rhlR_TT_Plux_CmRssrA_lasI.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-4-2.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | <p class="text2">(3) Pcon_rhlR_TT_Plux_CmR (pSB6A1) + Plac_lasI (pSB3K3)</p>
| |
| − | <table width="980 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="980px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/e/e0/Tokyo_Tech_Pcon_rhlR_TT_CmR_Plac_lasI.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-4-3.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <p class="text2">(4) Pcon_rhlR_TT_Plux_CmR (pSB6A1) +promoter less_lasI (pSB3K3)</p>
| |
| − | <table width="980 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="980px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/30/Tokyo_Tech_Pcon_rhlR_TT_Plux_CmR_lasI.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-4-4.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <p class="text2">(5) Negative control1: Pcon_rhlR_TT_promoter less_CmR (pSB6A1) + Plac_lasI (pSB3K3)</p>
| |
| − | <table width="980 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="980px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/e/eb/Tokyo_Tech_Pcon_rhlR_TT_CmR_Plac_lasI.2png.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-4-5.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <p class="text2">(6) Negative cotrol2:Pcon_rhlR_TT_promoter less_CmR (pSB6A1) +promoter less_lasI (pSB3K3)</p>
| |
| − | <table width="980 px" border="0px">
| |
| − | <tr>
| |
| − | <td width="980px"><div align="center"><img src="https://static.igem.org/mediawiki/2015/4/45/Tokyo_Tech_Pcon_rhlR_TT_CmR_lasI.png"/>
| |
| − | </td>
| |
| − | </tr>
| |
| − | <tr>
| |
| − | <td width="980px">
| |
| − | <h4 align="center" class="fig"><strong>Fig. 3-1-4-6.</strong></h4>
| |
| − | <td>
| |
| − | </tr>
| |
| − | </table>
| |
| − | <h3 id="Protocol" class="sub5">4.2. Assay Protocol</h3>
| |
| − | <h3 id="Protol1" class="sub6">4.2.1. C4HSL-dependent CmR expression assay</h3>
| |
| − | <p class="text4">
| |
| − | <strong>-samples</strong><br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋ promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1) ＋ promoter less_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_promoter less_CmR (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_promoter less_CmR (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_promoter less_CmR (pSB6A1)＋promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_promoter less_CmR (pSB6A1)＋promoter less_lasI (pSB3K3)#2<br>
| |
| − | </p>
| |
| − | <p class="text4"><br>
| |
| − | <strong>-Procedure</strong><br>
| |
| − | 1. Prepare overnight cultures for the samples in 3 mL LB medium, containing ampicillin (50 microg/mL) and kanamycin (30 microg/mL) at 37°C for 12 hours.<br>
| |
| − | 2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp (50 microg/mL) and Kan (30 microg/mL) and grow the cells at 37°C until the observed OD590 reaches 0.5.<br>
| |
| − | 3. Centrifuge 1 mL of the sample at 5000g, RT for 1 minute.<br>
| |
| − | 4. Suspend the pellet in 1mL of LB containing Amp and Kan.<br>
| |
| − | 5. Add 30 microL of suspension in the following medium.<br>
| |
| − | ①)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + 50 microM C4HSL (30 microL) + Chloramphenicol (3 microL of 100 microg/mL)<br>
| |
| − | ②)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (30 microL) + Chloramphenicol (3 microL of 100 microg/mL)<br>
| |
| − | 6. Grow the samples of cells at 37°C for more than 8 hours.<br>
| |
| − | 7. Measure optical density every hour. (If the optical density is over 1.0, dilute the cell medium to 1/5.)<br><br>
| |
| − |
| |
| − | <h3 id="Protol2" class="sub6">4.2.2. C4HSL-dependent CmR expression assay (With an ssrA tag)</h3>
| |
| − | <p class="text4">
| |
| − | <strong>-samples</strong><br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋promoter less_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmR (pSB6A1)＋promoter less_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_promoter less _CmR (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_promoter less _CmR (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_promoter less _CmR (pSB6A1)＋promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_promoter less _CmR (pSB6A1)＋promoter less_lasI (pSB3K3)#2<br>
| |
| − | <br>
| |
| − | <strong>-Procedure</strong><br>
| |
| − | 1. Prepare overnight cultures for the samples in 3 mL LB medium, containing ampicillin (50 microg/mL) and kanamycin (30 microg/mL) at 37°C for 12 hours.<br>
| |
| − | 2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp (50 microg/mL) and Kan (30 microg/mL) and grow the cells at 37°C until the observed OD590 reaches 0.5.<br>
| |
| − | 3. Centrifuge 1 mL of the sample at 5000g, RT for 1 minute.<br>
| |
| − | 4. Suspend the pellet in 1mL of LB containing Amp and Kan.<br>
| |
| − | 5. Add 30 microL of suspension in the following medium.<br>
| |
| − | ①)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + 50 microM C4HSL (30 microL) + Chloramphenicol (3 microL of 100 microg/mL)<br>
| |
| − | ②)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (30 microL) + Chloramphenicol (3 microL of 100 microg/mL)<br>
| |
| − | 6. Grow the samples of cells at 37°C for more than 8 hours.<br>
| |
| − | 7. Measure optical density every hour. (If the optical density is over 1.0, dilute the cell medium to 1/5.)<br></p>
| |
| − | <h3 id="Protol3" class="sub6">4.2.3. Chloramphenicol-dependent Growth Assay with ssrA tag</h3>
| |
| − | <p class="text4">
| |
| − | <strong>-samples</strong><br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋promoter less_lasI (pSB3K3)#2<br>
| |
| − | <br><strong>-Procedure</strong><br>
| |
| − | 1. Prepare overnight cultures for the samples in 3 mL LB medium, containing ampicillin (50 microg/mL) and kanamycin (30 microg/mL) at 37°C for 12 hours.<br>
| |
| − | 2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp (50 microg/mL) and Kan (30 microg/mL) and grow the cells at 37°C until the observed OD590 reaches 0.5.<br>
| |
| − | 3. Centrifuge 1 mL of the sample at 5000g, RT for 1 minute.<br>
| |
| − | 4. Suspend the pellet in 1 mL of LB containing Amp and Kan.<br>
| |
| − | 5. Add 30 microL of suspension in the following medium.<br>
| |
| − | ①) LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (3 microL) + Chloramphenicol (6 microL of 25 microg/mL) + 99.5% ethanol (6 microL)<br>
| |
| − | ②) LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (3 microL) + Chloramphenicol (9 microL of 25 microg/mL) + 99.5% ethanol (3 microL)<br>
| |
| − | ③) LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (3 microL) + Chloramphenicol (12 microL of 25 microg/mL)<br>
| |
| − | 6. Grow the samples of cells at 37°C for more than 8 hours.<br>
| |
| − | 7. Measure the optical density every hour. (If the optical density is over 0.9, dilute the cell medium to 1/5.)<br>
| |
| − | <h3 id="Protol4" class="sub6">4.2.4. C4HSL-dependent CmR expression assay ([Cm] = 75 microg/mL)</h3>
| |
| − | <p class="text4">
| |
| − | <strong>-Samples</strong><br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋Plac_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋Plac_lasI (pSB3K3)#2<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋promoter less_lasI (pSB3K3)#1<br>
| |
| − | Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1)＋promoter less_lasI (pSB3K3)#2<br>
| |
| − | <br><strong>-Procedure</strong><br>
| |
| − | 1. Prepare overnight cultures for the samples in 3 mL LB medium, containing ampicillin (50 microg/mL) and kanamycin (30 microg/mL) at 37°C for 12 hours.<br>
| |
| − | 2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp (50 microg/mL) and Kan (30 microg/mL) and grow the cells at 37°C until the observed OD590 reaches 0.5.<br>
| |
| − | 3. Centrifuge 1 mL of the sample at 5000g, RT for 1 minute.<br>
| |
| − | 4. Suspend the pellet in 1mL of LB containing Amp and Kan.<br>
| |
| − | 5. Add 30 microL of suspension in the following medium.<br>
| |
| − | ①) LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + 50 microM C4HSL (30 microL) + Chloramphenicol (75 microg/mL)<br>
| |
| − | ②) LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (30 microL) + Chloramphenicol (75 microg/mL)<br>
| |
| − | 6. Grow the samples of cells at 37°C for more than 8 hours.<br>
| |
| − | 7. Measure optical density every hour. (If the optical density is over 0.9, dilute the cell medium to 1/5.)<br>
| |
| − | <h2 id="Reference" class="smalltitle">5. Reference</h2>
| |
| − | <p class="text">1. Bo Hu <em>et al.</em> (2010) An Environment-Sensitive Synthetic Microbial Ecosystem. PLoS ONE 5(5): e10619</p>
| |
| − | </div>
| |
| − | <div class="textbottom">
| |
| − | <img src="https://static.igem.org/mediawiki/2015/9/97/Tokyo_Tech_textarea_bottom.png">
| |
| − | </div>
| |
| − | </body>
| |
| − | </html>
| |